Scott Shandler, Ph.D., MBA
CEO at Longevity Biotech, Inc.
Location: Philadelphia, Pennsylvania, United States
Scott Shandler, PhD, brings more than a decade of commercial and scientific operating experience to Longevity Biotech. As co-founder and CEO, Dr. Shandler is responsible for overseeing all discovery and product development activities. Previously, Dr. Shandler was a venture capitalist at BioAdvance, focused on investing in early-stage therapeutics. Prior to BioAdvance, he worked for Merck Research Labs and was responsible for guiding project prioritization efforts across the worldwide basic research neuroscience portfolio. Prior to Merck, Dr. Shandler was a product manager for PolyMedix. In addition, he served as a subject matter expert in Accenture’s Pharmaceutical and Medical Products group, advising leading pharmaceutical and biotechnology companies.
Dr. Shandler received his PhD in biochemistry and molecular biophysics from the University of Pennsylvania and an MBA from The Wharton School. He holds a BA in computer science from Brandeis University and a certificate of bioinformatics from Stanford University.